CompaniesTherapeuticsMD

TherapeuticsMD

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (7)
View all

Total Trials

7

As Lead Sponsor

6

As Collaborator

1

Total Enrollment

2,773

By Phase

PHASE1: 2PHASE3: 4PHASE2: 1

By Status

COMPLETED: 6TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Today
NCT01942668
NCT02224313
Hover over trial bars to see details

Recent Trials

NCT04272008Lead Sponsor
The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
PHASE1Completed
21 participants
Started: Mar 6, 2020 · Completed: Jun 8, 2021
NCT04290390Lead Sponsor
Annovera™ Drug-Drug Interaction Study
PHASE1Completed
67 participants
Started: Feb 12, 2020 · Completed: Jan 6, 2021
NCT02224313Collaborator
Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal Women
PHASE3Completed
20 participants
Started: Dec 31, 2015 · Completed: Aug 31, 2018
NCT02253173Lead Sponsor
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
PHASE3Completed
764 participants
Started: Sep 30, 2014 · Completed: Oct 31, 2015
NCT02019589Lead Sponsor
A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
PHASE3Terminated
6 participants
Started: Jan 20, 2014 · Completed: Oct 31, 2014
View all 7 trials →
Funding History (20)
8-K
Aug 12, 2025
Filing
8-K
May 13, 2025
Filing
8-K
Apr 9, 2025
Filing
8-K
Mar 27, 2025
Filing
8-K
Dec 5, 2024
Filing
8-K
Nov 12, 2024
Filing
DEFA14A
Oct 25, 2024
Filing
DEF 14A
Oct 25, 2024
Filing
8-K
Sep 20, 2024
Filing
8-K
Aug 12, 2024
Filing